Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion
July 11, 2025
United Therapeutics Presents Tyvaso DPI(TM) BREEZE Clinical Data At The European Respiratory Society International Congress 2021
September 7, 2021
Related Post
-
-
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants
July 11, 2025
-
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
July 10, 2025
-
Agenus’ BOT/BAL Achieves 42% Two-Year Survival in Refractory MSS CRC, Advances Toward Registration with FDA Alignment on Phase 3
July 7, 2025